Venclyxto 100 Tablets — Venetoclax 100 mg (112 Tabs) AbbVie
Venclyxto 100 mg (Venetoclax) is a breakthrough, original targeted cancer therapy. It is the first-in-class selective inhibitor of the BCL-2 protein. This protein builds up in certain cancer cells and prevents them from dying naturally. By blocking BCL-2, Venclyxto restores the apoptosis (programmed cell death) process, causing the rapid destruction of leukemia cells.
Manufacturer: AbbVie. 🇹🇷 Note: This specific product holds official Turkish registration and is packaged for the domestic market of Turkey, ensuring the highest standards of original medication quality.
Key Features:
- ✅ Unique Mechanism: Directly triggers the self-destruction sequence (apoptosis) within malignant cells.
- ✅ Deep Remission: Highly effective even in patients with challenging genetic profiles (e.g., 17p deletion or TP53 mutation).
- ✅ Original Brand: Manufactured by AbbVie, the original developer of the venetoclax molecule.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 02.04.2026
Similar products
What Customers Say
No reviews yet
Your review can be the first!